Accessibility: Skip TopNav
AXIM Photo 2.jpg
Dr. Marcus Meinardi leads AXIM Biotech’s AX-1602 human trials with cannabigerol (CBG) and other cannabinoids for psoriasis and eczema at Maurits Clinics in The Hague, The Netherlands.
Format
JPEG
Source
AXIM BIOTECHNOLOGIES, INC
Downloads
Original
Large
Medium
Small